title: Impact of global versus renal-specific sympathoinhibition in aldosterone-induced hypertension: implications for medical device-based treatment of resistant hypertension.
authors.affiliation: From the Department of Pharmacology and Experimental Therapeutics and the Whitaker Cardiovascular Institute, Boston University School of Medicine, MA.
authors.forename: Casey Y
authors.initials: CY
authors.lastname: Carmichael
authors.affiliation: From the Department of Pharmacology and Experimental Therapeutics and the Whitaker Cardiovascular Institute, Boston University School of Medicine, MA. rwainf@bu.edu.
authors.forename: Richard D
authors.initials: RD
authors.lastname: Wainford
mesh_terms: D000450:Aldosterone / Q000494:pharmacology*; D000818:Animals; D017704:Baroreflex / Q000502:physiology*; D006973:Hypertension / Q000601:surgery*; D008297:Male; D009638:Norepinephrine / Q000097:blood*; D012084:Renin-Angiotensin System / Q000187:drug effects*
chemical_list: D000450:Aldosterone; D009638:Norepinephrine